Chronic spontaneous urticaria

The invisible illness that affects quality of life

It is not simply a skin problem: it is, in fact, a complex chronic condition underpinned by immunological mechanisms. Reducing delays in diagnosis

(Adobe Stock)

3' min read

Translated by AI
Versione italiana

3' min read

Translated by AI
Versione italiana

It is estimated that chronic spontaneous urticaria affects around 1 per cent of the world’s population and almost 0.8 per cent of the Italian population. It is therefore not a rare condition. Yet it remains little understood and is often underestimated. Those who have never experienced it tend to regard it as a simple skin problem. In reality, it is a complex chronic condition, driven by immunological mechanisms, which can profoundly affect quality of life.

Symptoms of the condition

It presents with hives, intense itching and, in many cases, angioedema. The symptoms persist for more than six weeks and can affect the person for months or years. Above all, they occur without warning. It is this unpredictability that makes the condition so difficult to cope with: not knowing when the lesions will appear, how long they will last, or whether it will be possible to sleep, work, go out or keep a commitment.

Loading...

In my role as President of ARCO – the Association for Research and Treatment of Urticaria – I have had the opportunity to hear the stories of many people living with this condition. They rarely begin their stories by describing just the hives. Instead, they talk about sleepless nights, the struggle to get through the working day, and the embarrassment when the lesions suddenly appear on their face or hands. They tell of having to cancel a trip, the fear that an episode of angioedema might occur far from home, and the difficulty of explaining that the condition is not contagious.

Restoring balance to patients

These are different stories, but they all paint the same picture: that of a condition which intrudes on everyday life and profoundly alters its balance. Quality of life is now one of the most important indicators, even when assessing the effectiveness of treatment. Managing the condition means giving people back the chance to work, study, sleep, travel and nurture relationships without itch and uncertainty affecting every decision they make.

The scientific literature confirms what we patients have been reporting for some time: the impact of chronic spontaneous urticaria is undoubtedly significant on psychological well-being, productivity at work and participation in social life. It therefore affects not only those who suffer from it, but also their families, their workplaces and, more generally, society as a whole.

Research progress

In recent years, research has profoundly changed our understanding of the condition. We know that it is not the result of a food or environmental allergy, as many people still believe. We have a better understanding of the mechanisms that cause it, and we have diagnostic and treatment options that enable us to effectively control symptoms in the vast majority of patients.

Yet, diagnostic delays remain a reality. Many people arrive at the specialist centre after having consulted several healthcare professionals and undergone tests that are not always necessary. This process leads to a build-up of time, frustration and suffering, whilst their quality of life continues to deteriorate. Reducing this delay means offering patients the chance to access appropriate treatment sooner and to return to as normal a life as possible more quickly.

This is how Arco promotes dialogue

At ARCO, we work every day to raise awareness of chronic spontaneous urticaria, foster dialogue between patients, doctors, researchers and institutions, and help disseminate accurate information. Over the years, by listening to patients and their families, I have come to realise that their primary need is to feel recognised and taken seriously. Receiving an accurate diagnosis and knowing that the condition can now be managed changes the way one looks to the future.

Research has opened up possibilities that, until just a few years ago, seemed almost unimaginable. The challenge now is to ensure that these opportunities reach all patients, regardless of where they live or the journey they have been through prior to diagnosis. Because living with uncontrolled chronic spontaneous urticaria is not just about having hives or itching: it means giving up, every day, a part of one’s freedom. Restoring that freedom is the most important outcome that treatment can offer.

*Chair and founder of ARCO, the Association for Research and Treatment of Urticaria

Copyright reserved ©
Loading...

Brand connect

Loading...

Newsletter

Notizie e approfondimenti sugli avvenimenti politici, economici e finanziari.

Iscriviti